Home
Live Updates
BiVictriX sees positive final data in BVX001 leukaemia drug study : comparemela.com
BiVictriX sees positive final data in BVX001 leukaemia drug study
BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) has received positive final results from the second in vivo efficacy study of its lead clinical cancer...
Related Keywords
United States ,
,
Trademark Office ,
Bivictrix Therapeutics ,
Acute Myeloid Leukaemia ,
Tiffany Thorn ,
United States Patent ,
comparemela.com © 2020. All Rights Reserved.